|Day's Range||313.20 - 315.09|
|52 Week Range||256.08 - 320.48|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.25%|
Refiners’ cash flows have turned volatile over the past few quarters due to volatile refining earnings.
In 1Q17, Bio-Rad Laboratories’ (BIO) Life Science segment reported revenues of ~$174.3 million, which represents a YoY rise of ~5.1%.
MPC's valuations are above the peer averages likely because it's now in the process of restructuring its organization to unlock value.